HK1045332A1 - Compounds for therapy and diagnosis of lung cancer and methods for their use - Google Patents

Compounds for therapy and diagnosis of lung cancer and methods for their use

Info

Publication number
HK1045332A1
HK1045332A1 HK02106838.1A HK02106838A HK1045332A1 HK 1045332 A1 HK1045332 A1 HK 1045332A1 HK 02106838 A HK02106838 A HK 02106838A HK 1045332 A1 HK1045332 A1 HK 1045332A1
Authority
HK
Hong Kong
Prior art keywords
diagnosis
therapy
compounds
methods
lung cancer
Prior art date
Application number
HK02106838.1A
Other languages
Chinese (zh)
Inventor
G Reed Steven
J Lodes Michael
Mohamath Raodoh
Secrist Heather
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/370,838 external-priority patent/US6444425B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of HK1045332A1 publication Critical patent/HK1045332A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/55—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK02106838.1A 1999-04-02 2002-09-19 Compounds for therapy and diagnosis of lung cancer and methods for their use HK1045332A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28532399A 1999-04-02 1999-04-02
US09/370,838 US6444425B1 (en) 1999-04-02 1999-08-09 Compounds for therapy and diagnosis of lung cancer and methods for their use
US47623599A 1999-12-30 1999-12-30
US51880900A 2000-03-03 2000-03-03
PCT/US2000/008560 WO2000060077A2 (en) 1999-04-02 2000-03-30 Compounds for therapy and diagnosis of lung cancer and methods for their use

Publications (1)

Publication Number Publication Date
HK1045332A1 true HK1045332A1 (en) 2002-11-22

Family

ID=27501392

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106838.1A HK1045332A1 (en) 1999-04-02 2002-09-19 Compounds for therapy and diagnosis of lung cancer and methods for their use

Country Status (5)

Country Link
EP (1) EP1187915A2 (en)
JP (1) JP2002540790A (en)
AU (1) AU4185100A (en)
HK (1) HK1045332A1 (en)
WO (1) WO2000060077A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759508B2 (en) 2000-09-01 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
GB9924060D0 (en) * 1999-10-11 1999-12-15 Chiron Spa VIP54 protein
CZ20023567A3 (en) * 2000-03-29 2003-11-12 Corixa Corporation Compounds and methods for therapy and diagnosis of lung carcinoma
DE60130782T2 (en) * 2000-08-28 2008-07-03 Teijin Ltd. AIRWAY-SPECIFIC, TRYPSIN-SIMILAR ENZYMES AND METHODS FOR THEIR APPLICATION
US20050085627A1 (en) 2001-06-21 2005-04-21 Youming Zhang Atopy
AU2007216892B2 (en) * 2002-08-16 2011-02-10 Agensys, Inc. Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer
US20040081653A1 (en) * 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
US7906620B2 (en) * 2002-08-16 2011-03-15 Yeda Research And Development Co. Ltd. Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
JP5648261B2 (en) * 2006-12-20 2015-01-07 東レ株式会社 Cancer detection method
PL2322221T3 (en) 2008-08-05 2015-01-30 Toray Industries Pharmaceutical composition for treatment and prevention of cancer
DK2325648T3 (en) * 2008-08-05 2014-07-28 Toray Industries METHOD OF DETECTING CANCER
CA2788715C (en) 2010-02-04 2021-06-08 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
WO2011096533A1 (en) * 2010-02-04 2011-08-11 東レ株式会社 Pharmaceutical composition for treatment and/or prevention of cancer
CN109925511B (en) 2010-02-04 2024-03-19 东丽株式会社 Medicine for treating and/or preventing cancer
EP2532364B1 (en) * 2010-02-04 2016-05-04 Toray Industries, Inc. Pharmaceutical composition comprising anti caprin-1 antibodies for treating and/or preventing cancer
PT2532743E (en) 2010-02-04 2015-08-04 Toray Industries Pharmaceutical composition for treatment and/or prevention of cancer
AU2011211684B2 (en) 2010-02-04 2014-09-25 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
DK2741085T3 (en) 2011-08-04 2017-06-19 Toray Industries Method for detecting pancreatic cancer
HUE030130T2 (en) 2011-08-04 2017-04-28 Toray Industries Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
PL2740793T3 (en) 2011-08-04 2018-04-30 Toray Industries, Inc. Drug composition for cancer treatment and/or prevention
CA2844034C (en) 2011-08-04 2019-07-16 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
TR201808595T4 (en) 2011-08-04 2018-07-23 Toray Industries Pharmaceutical composition for the treatment and / or prophylaxis of cancer diseases.
JP6070191B2 (en) 2011-08-04 2017-02-01 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
JP6065592B2 (en) 2011-08-04 2017-01-25 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
ES2749672T3 (en) 2012-02-21 2020-03-23 Toray Industries Pharmaceutical composition to treat and / or prevent cancer
KR102009236B1 (en) 2012-02-21 2019-08-09 도레이 카부시키가이샤 Pharmaceutical composition for treatment and/or prevention of cancer
HUE034736T2 (en) 2012-02-21 2018-02-28 Toray Industries Medicinal composition for treating and/or preventing cancer
JP6187255B2 (en) 2012-02-21 2017-08-30 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
CA2869123C (en) 2012-03-30 2021-03-16 Toray Industries, Inc. Pharmaceutical composition comprising anti-caprin-1 antibodies for the treatment of gallbladder cancer
RU2640245C2 (en) 2012-03-30 2017-12-27 Торэй Индастриз, Инк. Pharmaceutical composition for liver cancer treatment and/or prevention
PT2876446T (en) 2012-07-19 2019-03-25 Toray Industries Method for detecting cancer
MX358772B (en) 2012-07-19 2018-09-04 Toray Industries Cancer detection method.
PL3031826T3 (en) 2013-08-09 2019-03-29 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
ID27813A (en) * 1998-01-28 2001-04-26 Corixa Corp COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE

Also Published As

Publication number Publication date
AU4185100A (en) 2000-10-23
EP1187915A2 (en) 2002-03-20
JP2002540790A (en) 2002-12-03
WO2000060077A2 (en) 2000-10-12
WO2000060077A3 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
HK1045332A1 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
HUP0200760A2 (en) Compounds and methods for therapy and diagnosis of lung cancer
HUP0201757A2 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
ZA99693B (en) Compounds for therapy and diagnosis of lung cancer and methods for their use.
PL366626A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
GB9903841D0 (en) Diagnosis and treatment of cancer
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
PL346359A1 (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1516049A4 (en) Compositions and methods for the therapy and diagnosis of lung cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
EP1446013A4 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
HUP0200991A2 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
EP1420814A4 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL366066A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003230849A8 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer